Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.
from Latest News https://ift.tt/2BvORni
How Moderna execs are cashing in on COVID-19 vaccine stock speculation
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment